Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus

BACKGROUND: Symmetric dimethylarginine (SDMA) has been increasingly used as a marker of early chronic kidney disease (CKD) in cats, but little is known about the influence of comorbidities on SDMA in this species. HYPOTHESIS: Hypertrophic cardiomyopathy (HCM) and diabetes mellitus (DM), independentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Langhorn, R., Kieler, I.N., Koch, J., Christiansen, L.B., Jessen, L.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787200/
https://www.ncbi.nlm.nih.gov/pubmed/29230874
http://dx.doi.org/10.1111/jvim.14902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787200/
https://www.ncbi.nlm.nih.gov/pubmed/29230874
http://dx.doi.org/10.1111/jvim.14902

Ejemplares similares